Yasuyuki Seto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yasuyuki Seto has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Shigekazu Ohyama
Japanese Foundation for Cancer Research
7 shared publications Toshiharu Yamaguchi
7 shared publications- Naoki Hiki
Department of Upper Gastrointestinal Surgery Kitasato University School of Medicine Sagamihara Kanagawa Japan
6 shared publications Tetsu Fukunaga
5 shared publications- Masanori Tokunaga
Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
4 shared publications Takashi Fukuda
3 shared publications
Latest Publications
- 1 February 2011
- Vol. 38 (2) , 184-6
[Current state of treatment for advanced gastric cancer].
The radical treatment of gastric cancer is complete resection of the tumor by surgery. For advanced gastric cancer, a multidisciplinary approach has been attempted to improve patient prognosis. Potentially resectable and curable advanced gastric cancer is treated with routine surgery, followed by postoperative adjuvant chemotherapy. For highly advanced gastric cancer, extended radical surgery or preoperative adjuvant chemotherapy have been attempted. Laparoscopic gastrectomy for advanced gastric cancer has not been widely used because of the difficult surgical technique involved, but enhanced magnification in the surgical field is expected to improve the accuracy of the lymph node dissection procedure. In future, the significance of currently available treatments should be investigated. The key treatment for advanced gastric cancer at present is surgery.
- 1 February 2011
- Vol. 38 (2) , 184-6
[Current state of treatment for advanced gastric cancer].
The radical treatment of gastric cancer is complete resection of the tumor by surgery. For advanced gastric cancer, a multidisciplinary approach has been attempted to improve patient prognosis. Potentially resectable and curable advanced gastric cancer is treated with routine surgery, followed by postoperative adjuvant chemotherapy. For highly advanced gastric cancer, extended radical surgery or preoperative adjuvant chemotherapy have been attempted. Laparoscopic gastrectomy for advanced gastric cancer has not been widely used because of the difficult surgical technique involved, but enhanced magnification in the surgical field is expected to improve the accuracy of the lymph node dissection procedure. In future, the significance of currently available treatments should be investigated. The key treatment for advanced gastric cancer at present is surgery.
- 24 December 2008
- Vol. 55, 1855-8
Incidence of gastric cancer in the remnant stomach after proximal gastrectomy.
Gastric cancer in the remnant stomach after proximal gastrectomy has not been studied in detail. The aim of this study was to clarify the incidence of this type of cancer. From 478 cases of radical proximal gastrectomy followed prospectively, those that developed gastric cancer in the remnant stomach were identified. The incidence of gastric cancer in the remnant stomach in the cohort was compared with the expected incidence of gastric cancer in the general population. Gastric cancer in the remnant stomach occurred in 8 (6 males, 2 females) of 478 patients (1.7%). The duration from primary gastrectomy to gastric cancer in the remnant stomach detection was over 10 years in 3 cases. In males, the rate of the incidence of gastric cancer in the remnant stomach was lower than the expected incidence for all durations. In females, the rate was also low, but appeared slightly elevated from 6 to 10 years and from 16 to 20 years after the primary gastrectomy. The incidence of proximal gastrectomy after proximal gastrectomy is not high, and the risk in males is especially low. However, proximal gastrectomy may develop over 10 years after surgery, and long-term follow-up is essential.
- 24 December 2008
- Vol. 55, 1855-8
Incidence of gastric cancer in the remnant stomach after proximal gastrectomy.
Gastric cancer in the remnant stomach after proximal gastrectomy has not been studied in detail. The aim of this study was to clarify the incidence of this type of cancer. From 478 cases of radical proximal gastrectomy followed prospectively, those that developed gastric cancer in the remnant stomach were identified. The incidence of gastric cancer in the remnant stomach in the cohort was compared with the expected incidence of gastric cancer in the general population. Gastric cancer in the remnant stomach occurred in 8 (6 males, 2 females) of 478 patients (1.7%). The duration from primary gastrectomy to gastric cancer in the remnant stomach detection was over 10 years in 3 cases. In males, the rate of the incidence of gastric cancer in the remnant stomach was lower than the expected incidence for all durations. In females, the rate was also low, but appeared slightly elevated from 6 to 10 years and from 16 to 20 years after the primary gastrectomy. The incidence of proximal gastrectomy after proximal gastrectomy is not high, and the risk in males is especially low. However, proximal gastrectomy may develop over 10 years after surgery, and long-term follow-up is essential.
- Open Access
- 1 November 2008
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 21 (8) , 704-707
Celiac lymph nodes: distant or regional for thoracic esophageal carcinoma?
- 1 November 2008
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 21 (8) , 704-707
Open AccessCeliac lymph nodes: distant or regional for thoracic esophageal carcinoma?
- 1 January 2008
- Vol. 17, 121-5
Cut-and-screw insertion: a method for safe and speedy secondary trocar insertion in laparoscopic surgery.
Laparoscopic surgery is increasingly applied to the treatment of gastrointestinal disease. However, the insertion of secondary trocars following pneumoperitoneum carries the risk of serious complications such as major vascular and bowel injuries. Such injury can arise when the force required for the trocar insertion is such that it causes the operator to have impaired control over the entry. There is a need for a procedure of secondary trocar insertion that is safe and easy to perform for training clinicians in laparoscopic surgery. We have developed the "cut-and-screw" insertion method for secondary trocar insertion using a specially developed laparoscopic cannula with a sharp edge and housing. Our procedure is simple, rapid, and safe. In this chapter, we describe the technique and present our initial clinical results.
- 1 January 2008
- Vol. 17, 121-5
Cut-and-screw insertion: a method for safe and speedy secondary trocar insertion in laparoscopic surgery.
Laparoscopic surgery is increasingly applied to the treatment of gastrointestinal disease. However, the insertion of secondary trocars following pneumoperitoneum carries the risk of serious complications such as major vascular and bowel injuries. Such injury can arise when the force required for the trocar insertion is such that it causes the operator to have impaired control over the entry. There is a need for a procedure of secondary trocar insertion that is safe and easy to perform for training clinicians in laparoscopic surgery. We have developed the "cut-and-screw" insertion method for secondary trocar insertion using a specially developed laparoscopic cannula with a sharp edge and housing. Our procedure is simple, rapid, and safe. In this chapter, we describe the technique and present our initial clinical results.
- 1 January 2008
- Published by The Japanese Journal of Gastroenterological Surgery in The Japanese Journal of Gastroenterological Surgery
- Vol. 41 (9) , 1661-1668
New Technique for Laparoscopic Wedge Resection for Gastric Submucosal Tumor: (Laparoscopy Endoscopy Cooperative Surgery)
はじめに: 胃粘膜下腫瘍に対する腹腔鏡下切除は積極的に行われているが, 胃内発育型腫瘍の切除では, 過剰な胃粘膜が切除され, 術後の変形を来すこともある. さらに, 胃食道移行部, 幽門輪近傍の病変では, 噴門側, 幽門側胃切除といった術式が選択されることもある. 方法: 2006年7月より2007年7月に胃内発育型胃粘膜下腫瘍に対して腹腔鏡・内視鏡合同胃局所切除 (laparoscopy endoscopy cooperative surgery; 以下, LECS)を行った12例の手術成績を従来の腹腔鏡下胃局所切除17例と比較した. 結果: LECSは, 内視鏡的粘膜下層切開剥離術を用いて, 胃内腔から切除線を決定し, 腹腔鏡下で漿膜・筋層切開を行い, 腫瘍摘出を行う方法である.手術時間, 術中出血量, 自動縫合器使用数, 開腹移行率, 術後の胃拡張, 食事摂取開始時期, 在院日数を調べた. 結果: LECSは胃食道移行部, 幽門輪近傍の病変を含む12例で, 開腹への移行や合併症なく施行され, 術後成績も従来法と同等であった. LECSの平均手術時間は約30分従来法より長く, 術中出血は約12ml多かった. 自動吻合器使用数 (2.1±0.8回)は, 対照 (3.2±0.5回)より有意に少なかった. 考察: LECSは最小限の胃壁切除で胃粘膜下腫瘍切除が可能であり, 胃食道移行部, 幽門輪近傍の病変にも応用可能である.
- 1 January 2008
- Published by The Japanese Journal of Gastroenterological Surgery in The Japanese Journal of Gastroenterological Surgery
- Vol. 41 (9) , 1661-1668
New Technique for Laparoscopic Wedge Resection for Gastric Submucosal Tumor: (Laparoscopy Endoscopy Cooperative Surgery)
はじめに: 胃粘膜下腫瘍に対する腹腔鏡下切除は積極的に行われているが, 胃内発育型腫瘍の切除では, 過剰な胃粘膜が切除され, 術後の変形を来すこともある. さらに, 胃食道移行部, 幽門輪近傍の病変では, 噴門側, 幽門側胃切除といった術式が選択されることもある. 方法: 2006年7月より2007年7月に胃内発育型胃粘膜下腫瘍に対して腹腔鏡・内視鏡合同胃局所切除 (laparoscopy endoscopy cooperative surgery; 以下, LECS)を行った12例の手術成績を従来の腹腔鏡下胃局所切除17例と比較した. 結果: LECSは, 内視鏡的粘膜下層切開剥離術を用いて, 胃内腔から切除線を決定し, 腹腔鏡下で漿膜・筋層切開を行い, 腫瘍摘出を行う方法である.手術時間, 術中出血量, 自動縫合器使用数, 開腹移行率, 術後の胃拡張, 食事摂取開始時期, 在院日数を調べた. 結果: LECSは胃食道移行部, 幽門輪近傍の病変を含む12例で, 開腹への移行や合併症なく施行され, 術後成績も従来法と同等であった. LECSの平均手術時間は約30分従来法より長く, 術中出血は約12ml多かった. 自動吻合器使用数 (2.1±0.8回)は, 対照 (3.2±0.5回)より有意に少なかった. 考察: LECSは最小限の胃壁切除で胃粘膜下腫瘍切除が可能であり, 胃食道移行部, 幽門輪近傍の病変にも応用可能である.
- 1 June 2007
- Published by Elsevier in The American Journal of Surgery
- Vol. 193 (6) , 792-793
Esophageal bypass using a gastric tube and a cardiostomy for malignant esophagorespiratory fistula
- 1 June 2007
- Published by Elsevier in The American Journal of Surgery
- Vol. 193 (6) , 792-793
Esophageal bypass using a gastric tube and a cardiostomy for malignant esophagorespiratory fistula
- Open Access
- 18 April 2007
- Published by Wiley in Cancer Science
- Vol. 98 (7) , 937-942
Treatment of thoracic esophageal carcinoma invading adjacent structures
T4 esophageal cancer is defined as the tumor invading adjacent structures, using tumor–node–metastasis (TNM) staging. For clinically T4 thoracic esophageal carcinoma, multimodality therapy, that is, neoadjuvant chemoradiotherapy (CRT) followed by surgery or definitive CRT, has generally been performed. However, the prognosis of patients with these tumors remains poor. Another strategy is needed to achieve curative treatment. In the present article, the treatment strategies employed to date are reviewed. Furthermore, the strategies for these malignancies are reassessed, based on our experiences. R1/2 and R0 resections are regarded as those with residual and no tumor after surgery. The present data show that patients who underwent R1/2 resection after neoadjuvant CRT experienced little survival benefit, while complete response (CR) cases after definitive CRT had comparatively better results. Therefore, curative surgery should not be attempted without down‐staging, and definitive CRT should be the initial treatment. Then surgery is indicated for the eradication of residual cancer cells. Close surveillance is essential for early detection of relapse even after CR, because the operation will gradually become increasingly difficult due to post‐CRT fibrosis. In conclusion, multimodality therapy consists of definitive CRT followed by R0 resection, which can be the treatment of choice for T4 esophageal carcinoma. These challenging treatments have the potential to constitute the most effective therapeutic strategy. (Cancer Sci 2007; 98: 937–942)
- 18 April 2007
- Published by Wiley in Cancer Science
- Vol. 98 (7) , 937-942
Open AccessTreatment of thoracic esophageal carcinoma invading adjacent structures
T4 esophageal cancer is defined as the tumor invading adjacent structures, using tumor–node–metastasis (TNM) staging. For clinically T4 thoracic esophageal carcinoma, multimodality therapy, that is, neoadjuvant chemoradiotherapy (CRT) followed by surgery or definitive CRT, has generally been performed. However, the prognosis of patients with these tumors remains poor. Another strategy is needed to achieve curative treatment. In the present article, the treatment strategies employed to date are reviewed. Furthermore, the strategies for these malignancies are reassessed, based on our experiences. R1/2 and R0 resections are regarded as those with residual and no tumor after surgery. The present data show that patients who underwent R1/2 resection after neoadjuvant CRT experienced little survival benefit, while complete response (CR) cases after definitive CRT had comparatively better results. Therefore, curative surgery should not be attempted without down‐staging, and definitive CRT should be the initial treatment. Then surgery is indicated for the eradication of residual cancer cells. Close surveillance is essential for early detection of relapse even after CR, because the operation will gradually become increasingly difficult due to post‐CRT fibrosis. In conclusion, multimodality therapy consists of definitive CRT followed by R0 resection, which can be the treatment of choice for T4 esophageal carcinoma. These challenging treatments have the potential to constitute the most effective therapeutic strategy. (Cancer Sci 2007; 98: 937–942)
- 1 January 2007
- Published by The Japanese Journal of Gastroenterological Surgery in The Japanese Journal of Gastroenterological Surgery
- Vol. 40 (8) , 1479-1484
A Case of Advanced Gastric Cancer-Histological CR was Attained by One Course of Neoadjuvant Chemotherapy with S-1/CDDP
- 1 January 2007
- Published by The Japanese Journal of Gastroenterological Surgery in The Japanese Journal of Gastroenterological Surgery
- Vol. 40 (8) , 1479-1484
A Case of Advanced Gastric Cancer-Histological CR was Attained by One Course of Neoadjuvant Chemotherapy with S-1/CDDP
- 1 November 2006
- Vol. 33 (11) , 1553-6
[Cancer board--new medical system in cancer clinic].
To proceed with more patient-oriented cancer medicine, the development of a new medical system is necessary in Japan. In Ariake Hospital of the Japanese Foundation for Cancer Research, a new medical system has been developed, which is composed of a common outpatient clinic and a conference system. The core conference system is called "Cancer Board". The practice of patient-oriented medicine in gastroenterological cancer has been introduced as a sample of the Cancer Board system in our hospital.
- 1 November 2006
- Vol. 33 (11) , 1553-6
[Cancer board--new medical system in cancer clinic].
To proceed with more patient-oriented cancer medicine, the development of a new medical system is necessary in Japan. In Ariake Hospital of the Japanese Foundation for Cancer Research, a new medical system has been developed, which is composed of a common outpatient clinic and a conference system. The core conference system is called "Cancer Board". The practice of patient-oriented medicine in gastroenterological cancer has been introduced as a sample of the Cancer Board system in our hospital.
- Open Access
- 1 January 2006
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 67 (11) , 2604-2608
FIVE CASES OF GASTRIC CANCER WITH ADACHI TYPE VI VASCULAR ANOMALY IN WHICH PREOPERATIVE DIAGNOSIS WAS MADE BY MDCT AND 3D-ANGIOGRAPHY
- 1 January 2006
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 67 (11) , 2604-2608
Open AccessFIVE CASES OF GASTRIC CANCER WITH ADACHI TYPE VI VASCULAR ANOMALY IN WHICH PREOPERATIVE DIAGNOSIS WAS MADE BY MDCT AND 3D-ANGIOGRAPHY